Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Sharp

Showing results (31-40 of 113) with videos related to

Pageof 12
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|August 20, 2009
Thioflavin S (NSC71948) interferes with Bcl-2-associated athanogene (BAG-1)-mediated protein-protein interactionsAdam Sharp, Simon J Crabb, Peter W M Johnson, et al.
Journal of Hematology & Oncology|July 3, 2025
Treatment-related adverse events of antibody drug-conjugates in clinical trialsHarold Nathan Tan, Marta Ascanio Morcillo, Juanita Lopez, et al.
Nature Reviews. Clinical Oncology|August 24, 2018
Alternative splicing in prostate cancerAlec Paschalis, Adam Sharp, Jonathan C Welti, et al.
JAMA Network Open|December 19, 2023
Emergency Department Cardiac Risk Stratification With High-Sensitivity vs Conventional Troponin HEART PathwayMackensie Yore, Adam Sharp, Yi-Lin Wu, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|February 15, 2020
Impact of Physician-Patient Language Concordance on Patient Outcomes and Adherence to Clinical Chest Pain RecommendationsDanielle E Altman, Benjamin C Sun, Bryan Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2019
Dissecting Prognostic From Predictive Utility: Circulating AR-V7 Biomarker Testing for Advanced Prostate CancerAdam Sharp, Nuria Porta, Maryou B K Lambros, et al.
Annual Review of Pharmacology and Toxicology|August 27, 2021
A New Old Target: Androgen Receptor Signaling and Advanced Prostate CancerDaniel Westaby, Maria de Los Dolores Fenor de La Maza, Alec Paschalis, et al.
Cancer Chemotherapy and Pharmacology|December 27, 2015
A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patientsRajiv Kumar, Shir Kiong Lu, Anna Minchom, et al.
Cancer Reports (Hoboken, N.J.)|June 26, 2024
A single-centre study evaluating a geriatric screening tool in oncology phase I trial patientsMary Van Zyl, Anne Barell, Bridget Cooley, et al.
European Urology|April 28, 2016
Analytical Validation and Clinical Qualification of a New Immunohistochemical Assay for Androgen Receptor Splice Variant-7 Protein Expression in Metastatic Castration-resistant Prostate CancerJonathan Welti, Daniel Nava Rodrigues, Adam Sharp, et al.
Pageof 12

Showing results (31-40 of 113) with videos related to

Sort By:
Pageof 12
The Journal of Pharmacology and Experimental Therapeutics|August 20, 2009
Thioflavin S (NSC71948) interferes with Bcl-2-associated athanogene (BAG-1)-mediated protein-protein interactionsAdam Sharp, Simon J Crabb, Peter W M Johnson, et al.
Journal of Hematology & Oncology|July 3, 2025
Treatment-related adverse events of antibody drug-conjugates in clinical trialsHarold Nathan Tan, Marta Ascanio Morcillo, Juanita Lopez, et al.
Nature Reviews. Clinical Oncology|August 24, 2018
Alternative splicing in prostate cancerAlec Paschalis, Adam Sharp, Jonathan C Welti, et al.
JAMA Network Open|December 19, 2023
Emergency Department Cardiac Risk Stratification With High-Sensitivity vs Conventional Troponin HEART PathwayMackensie Yore, Adam Sharp, Yi-Lin Wu, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|February 15, 2020
Impact of Physician-Patient Language Concordance on Patient Outcomes and Adherence to Clinical Chest Pain RecommendationsDanielle E Altman, Benjamin C Sun, Bryan Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2019
Dissecting Prognostic From Predictive Utility: Circulating AR-V7 Biomarker Testing for Advanced Prostate CancerAdam Sharp, Nuria Porta, Maryou B K Lambros, et al.
Annual Review of Pharmacology and Toxicology|August 27, 2021
A New Old Target: Androgen Receptor Signaling and Advanced Prostate CancerDaniel Westaby, Maria de Los Dolores Fenor de La Maza, Alec Paschalis, et al.
Cancer Chemotherapy and Pharmacology|December 27, 2015
A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patientsRajiv Kumar, Shir Kiong Lu, Anna Minchom, et al.
Cancer Reports (Hoboken, N.J.)|June 26, 2024
A single-centre study evaluating a geriatric screening tool in oncology phase I trial patientsMary Van Zyl, Anne Barell, Bridget Cooley, et al.
European Urology|April 28, 2016
Analytical Validation and Clinical Qualification of a New Immunohistochemical Assay for Androgen Receptor Splice Variant-7 Protein Expression in Metastatic Castration-resistant Prostate CancerJonathan Welti, Daniel Nava Rodrigues, Adam Sharp, et al.
Pageof 12